Published in FEBS Lett on September 06, 1982
A glucagon-like peptide, structurally related to mammalian oxyntomodulin, from the pancreas of a holocephalan fish, Hydrolagus colliei. Biochem J (1987) 0.87
Identification of glucagon receptors in rat brain. Proc Natl Acad Sci U S A (1984) 0.85
The role of gastrointestinal hormones in the pathogenesis of obesity and type 2 diabetes. Prz Gastroenterol (2014) 0.78
Oxyntomodulin reduces hydromineral transport through rat small intestine. Dig Dis Sci (1998) 0.75
Polypeptide with broad biological activity: isolation from small intestine. Science (1970) 4.14
Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature (1982) 4.06
Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand (1982) 3.25
Separation of antibody-bound and unbound peptide hormones labelled with iodine-131 by talcum powder and precipitated silica. Nature (1966) 3.17
Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett (1983) 3.12
Structure of porcine cholecystokinin-pancreozymin. 1. Cleavage with thrombin and with trypsin. Eur J Biochem (1968) 2.72
Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc Natl Acad Sci U S A (1989) 2.59
Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur J Biochem (1972) 2.59
Structure of porcine secretin. The amino acid sequence. Eur J Biochem (1970) 2.44
Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature (1980) 2.31
Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun (1979) 2.16
Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature (1987) 2.09
N-terminally extended somatostatin: the primary structure of somatostatin-28. FEBS Lett (1980) 2.04
Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: functional significance of coexisting transmitters for vasodilation and secretion. Proc Natl Acad Sci U S A (1980) 2.00
Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem (1991) 1.95
Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci U S A (1982) 1.95
Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia (1980) 1.74
Structure of the porcine vasoactive intestinal octacosapeptide. The amino-acid sequence. Use of kallikrein in its determination. Eur J Biochem (1974) 1.71
Impairment of insulin binding to the fat cell plasma membrane in the obese hyperglycemic mouse. FEBS Lett (1972) 1.71
Structural homologies between prealbumin, gastrointestinal prohormones and other proteins. Nature (1981) 1.69
Isolation and characterization of the intestinal peptide porcine PHI (PHI-27), a new member of the glucagon--secretin family. Proc Natl Acad Sci U S A (1981) 1.63
A galanin-like peptide in the central nervous system and intestine of the rat. Neurosci Lett (1984) 1.63
The further purification of motilin, a gastric motor activity stimulating polypeptide from the mucosa of the small intestine of hogs. Can J Physiol Pharmacol (1971) 1.62
Cholecystokinin and pancreozymin, one single hormone? Acta Physiol Scand (1966) 1.51
Chemical determination of polypeptide hormones. Proc Natl Acad Sci U S A (1978) 1.47
Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience (1984) 1.41
Isolation of aspartyl-phenylalanine amide from cholecystokinin-pancreozymin. Biochem Biophys Res Commun (1967) 1.37
Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release. Eur J Biochem (1988) 1.34
Preparation of highly active enterogastrone. Can J Physiol Pharmacol (1969) 1.30
Potent peripheral and splanchnic vasodilator peptide from normal gut. Nature (1970) 1.30
Diabetogenic effect of streptozotocin in the rat during the perinatal period. Diabetes (1974) 1.27
A glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagon. Nature (1987) 1.24
Distribution of galanin-like immunoreactivity in the gastro-intestinal tract of several mammalian species. Cell Tissue Res (1985) 1.22
Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in culture. Proc Natl Acad Sci U S A (1978) 1.21
On the biological assay of secretin. The reference standard. Acta Physiol Scand (1966) 1.15
Further investigations of intestinal hormonal polypeptides. Clin Endocrinol (Oxf) (1976) 1.15
Galanin inhibits insulin secretion and induces hyperglycemia in dogs. Diabetes (1985) 1.12
[The effects of perfusion and amino acid ingestion in glucagonenemia]. Journ Annu Diabetol Hotel Dieu (1967) 1.11
Porcine peptide having N-terminal histidine and C-terminal isoleucine amide (PHI): vasoactive intestinal peptide (VIP) and secretin-like effects in different tissues from the rat. FEBS Lett (1980) 1.11
Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa. Int J Cancer (2000) 1.11
Further purification of a polypeptide demonstrating enterogastrone activity. J Physiol (1970) 1.10
Membrane-cytoskeleton dynamics in rat parietal cells: mobilization of actin and spectrin upon stimulation of gastric acid secretion. J Cell Biol (1989) 1.08
Neuropeptide Y (NPY)- and FMRFamide neuropeptide-like immunoreactivities in catecholamine neurons of the rat medulla oblongata. Acta Physiol Scand (1983) 1.08
Pancreastatin and islet hormone release. Proc Natl Acad Sci U S A (1987) 1.08
Neuropeptide Y in vitro selectivity increases the number of alpha 2-adrenergic binding sites in membranes of the medulla oblongata of the rat. Acta Physiol Scand (1983) 1.07
Amino acid sequence and heterogeneity of gastric inhibitory polypeptide (GIP). FEBS Lett (1981) 1.06
The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. J Hypertens (1996) 1.05
A gastrin releasing peptide from the porcine nonantral gastric tissue. Gut (1978) 1.05
Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage. Radiology (1993) 1.05
Interaction of a newly isolated intestinal polypeptide (PHI) with glucose and arginine to effect the secretion of insulin and glucagon. Life Sci (1980) 1.04
Inhibition of interdigestive contractile activity in the stomach by peptide YY in Heidenhain pouch dogs. Gastroenterology (1983) 1.03
Interactions of glucagon, gut glucagon, vasoactive intestinal polypeptide and secretin with liver and fat cell plasma membranes: binding to specific sites and stimulation of adenylate cyclase. Endocrinology (1974) 1.03
Labial salivary gland biopsy is a reliable test for the diagnosis of primary and secondary amyloidosis. A prospective clinical and immunohistologic study in 59 patients. Arthritis Rheum (1993) 1.02
Quercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway. Br J Pharmacol (2010) 1.02
Neuropeptide K: isolation, structure and biological activities of a novel brain tachykinin. Biochem Biophys Res Commun (1985) 1.02
Actions of a newly isolated intestinal peptide PHI on pancreatic acini. Am J Physiol (1981) 1.02
Contemporary developments in the biochemistry of the gastrointestinal hormones. Recent Prog Horm Res (1967) 1.01
Demonstration of specific receptors for EGF--urogastrone in isolated rat intestinal epithelial cells. FEBS Lett (1980) 1.01
Chicken insulin: radioimmunological characterization and enhanced activity in rat fat cells and liver plasma membranes. Endocrinology (1974) 1.01
Secretin-like bioactivity in extracts of porcine brain. Life Sci (1979) 1.01
Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat. Acta Physiol Scand (1983) 1.01
High plasma nonesterified fatty acids are predictive of cancer mortality but not of coronary heart disease mortality: results from the Paris Prospective Study. Am J Epidemiol (2001) 0.99
Cyclic AMP production in isolated colonic epithelial crypts: a highly sensitive model for the evaluation of vasoactive intestinal peptide action in human intestine. Eur J Clin Invest (1980) 0.99
Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line. Endocrinology (1993) 0.98
Expression of glucagon-like peptide 1 receptor in a murine C cell line: regulation of calcitonin gene by glucagon-like peptide 1. FEBS Lett (1996) 0.98
Molecular cloning and tissue distribution of rat sarcosine dehydrogenase. Eur J Biochem (1998) 0.98
Evidence for the presence of insulin binding sites in isolated rat intestinal epithelial cells. Diabetologia (1980) 0.97
A binding site for [3H]glipizide in the rat cerebral cortex. Eur J Pharmacol (1987) 0.97
Human alpha-endosulfine, a possible regulator of sulfonylurea-sensitive KATP channel: molecular cloning, expression and biological properties. Proc Natl Acad Sci U S A (1998) 0.97
Isolation of a porcine intestinal peptide with C-terminal somatostatin. Biochem Biophys Res Commun (1978) 0.96
A qualitative comparison of canine plasma gastroenteropancreatic hormone response to bombesin and the porcine gastrin-releasing peptide (GRP). Regul Pept (1981) 0.96
Glucagon antibodies. Lancet (1965) 0.95
Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes. Diabetologia (1979) 0.95
Hormonal polypeptides of the upper intestine. Biochem J (1971) 0.94
The PHI (PHI-27)/corticotropin-releasing factor/enkephalin immunoreactive hypothalamic neuron: possible morphological basis for integrated control of prolactin, corticotropin, and growth hormone secretion. Proc Natl Acad Sci U S A (1983) 0.94
Symposium III: Hormones and hormone receptors. A morphological approach to surface receptors in islet and liver cells. Isr J Med Sci (1975) 0.94
Relationship of spasmogenic and smooth muscle relaxant peptides from normal lung to other vasoactive compounds. Nature (1977) 0.93
Endosulfine, an endogenous peptidic ligand for the sulfonylurea receptor: purification and partial characterization from ovine brain. Proc Natl Acad Sci U S A (1992) 0.92
Interaction of vasoactive intestinal peptide with isolated intestinal epithelial cells from rat. 1. Characterization, quantitative aspects and structural requirements of binding sites. Eur J Biochem (1979) 0.92
Neuropeptide Y receptor in the rat brain. Eur J Biochem (1984) 0.92
Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene. Cancer Res (1989) 0.92
Metabolic clearance rates of oxyntomodulin and glucagon in the rat: contribution of the kidney. Regul Pept (1990) 0.92
Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1. Life Sci (1983) 0.92
A novel form of the polypeptide PHI isolated in high yield from bovine upper intestine. Relationships to other peptides of the glucagon-secretin family. Eur J Biochem (1984) 0.92
Localization and possible function of peptidergic neurons and their interactions with central catecholamine neurons, and the central actions of gut hormones. Fed Proc (1979) 0.91
Vasoactive intestinal peptide (VIP): variation of the jejuno-ileal content in the developing rat as measured by radioreceptorassay. Acta Endocrinol (Copenh) (1977) 0.91
Transfection of fetal rat intestinal epithelial cells by viral oncogenes: establishment and characterization of the E1A-immortalized SLC-11 cell line. Proc Natl Acad Sci U S A (1989) 0.91
Isolation and characterization of a 60-residue intestinal peptide structurally related to the pancreatic secretory type of trypsin inhibitor: influence on insulin secretion. Proc Natl Acad Sci U S A (1989) 0.91
Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides. J Neural Transm Suppl (1983) 0.90
Vasoactive intestinal peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL release. FEBS Lett (1979) 0.90
Vasoactive intestinal peptide (VIP): brain distribution, subcellular localization and effect of deafferentation of the hypothalamus in male rats. Brain Res (1979) 0.90
Cholecystokinin (pancreozymin). 4. Synthesis and properties of a biologically active analogue of the C-terminal heptapeptide with epsilon-hydroxynorleucine sulfate replacing tyrosine sulfate. J Med Chem (1978) 0.90